223560-31-4

Upstream product

• 101-97-3 Ethyl 2-phenylethanoate 
• 534-03-2 serinol 
• 65415-04-5 methyl (2-phenylacetyl)-L-serinate 

Downstream Products

• 943655-64-9 N-(trans-2-phenyl-1,3-dioxan-5-yl)phenylacetamide 
• 943655-65-0 trans-N-[2-(4'-methylphenyl)-1,3-dioxan-5-yl]phenylacetamide 
• 943655-66-1 trans-N-[2-(4'-chlorophenyl)-1,3-dioxan-5-yl]phenylacetamide 
• 943655-67-2 trans-N-[2-(4'-nitrophenyl)-1,3-dioxan-5-yl]phenylacetamide 
• 943655-68-3 trans-N-[2-(3'-nitrophenyl)-1,3-dioxan-5-yl]phenylacetamide 
• 943655-74-1 cis-N-[2-((E)-phenylvinyl)-4-methyl-1,3-dioxan-5-yl]phenylacetamide 
• 943655-76-3 N-[trans-2-((E)-styryl)-1,3-dioxan-5-yl]phenylacetamide 
• 866612-77-3 N-[2-(2-oxo-ethyl)-[1,3]dioxan-5-yl]-2-phenyl-acetamide 
• 866612-72-8 N-[2-(2,2-dimethoxy-ethyl)-[1,3]dioxan-5-yl]-2-phenyl-acetamide 

Relevant academic research and scientific papers

Amidation of esters with amino alcohols using organobase catalysis

A catalytic protocol for the base-mediated amidation of unactivated esters with amino alcohol derivatives is reported. Investigations into mechanistic aspects of the process indicate that the reaction involves an initial transesterification, followed by an intramolecular rearrangement. The reaction is highly general in nature and can be extended to include the synthesis of oxazolidinone systems through use of dimethyl carbonate.

Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes

A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compounds were tested using the xylene-induced mouse ear edema model. Some of these compounds exhibited comparable or better anti-inflammatory activities than that of aspirin suggesting that they can be further developed as potential anti-inflammatory drug lead compounds. In addition, treatment of these anti-inflammatory agents did not prolong tail bleeding time in mice. The structure/activity relationships were also analyzed among these compounds.

Toward the development of chemoprevention agents. Part II: Chemo-enzymatic synthesis and anti-inflammatory activities of a new class of 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes

A new series of optically pure 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes were designed and synthesized via a chemo-enzymatic combined method to develop new chemoprevention agents. Twenty-four of newly synthesized compounds significantly inhibited xylene-induced rat ear edema and exhibited comparable or better anti-inflammatory activities than the reference drug aspirin. Treatment of these anti-inflammatory agents did not prolong the tail bleeding time in rat. In addition, 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes exhibited good membrane permeability based on in vitro Caco-2 cell monolayer permeability assay. Furthermore, some preliminary structure-activity relationships were further analyzed among these compounds. Taken together, 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes may represent a new class of anti-inflammatory drugs with safer pharmacological profile.

Novel synthesis and anti-inflammatory activities of 2,5-disubstituted- dioxacycloalkanes

A novel stereospecific synthetic route to obtain a series of 2,5-disubstituted-dioxacycloalkanes is reported. Using an in vivo inhibition assay by monitoring xylene-induced ear edema in mice, the structure-activity relationship of the dioxacycloalkane com